Lucatumumab

MedChem Express

Lucatumumab

10

Research Use Only

Monoclonal

98.18

Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research [1] [2] .

-80°C

12352203